Calcineurin inhibitor-free immunosuppressive protocol with basiliximab induction and everolimus in de novo liver transplant recipients

被引：0
|
作者：
Masetti, Michele [1 ]
Montalti, Roberto [1 ]
Rompianesi, Gianluca [1 ]
Romano, Antonio [1 ]
Guerrini, Gianpiero [1 ]
De Ruvo, Nicola [1 ]
Gerunda, Giorgio E. [1 ]
机构：
[1] Univ Modena, Liver Multivisceral Transplantat Ctr, Modena, Italy
来源：
TRANSPLANT INTERNATIONAL | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [31] BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen
    Lipshutz, GS
    Flechner, SM
    Govani, MV
    Vincenti, F
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) : 2132 - 2134
  • [32] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    [J]. HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [33] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
  • [34] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. TRANSPLANTATION, 2014, 98 : 714 - 715
  • [35] Everolimus as a Calcineurin Inhibitor-Sparing Immunosuppressive Agent in Lung Transplant Recipients With Renal Impairment
    Yo, Shaun
    Coughlan, Tim
    Ivulich, Steve
    Paul, Eldho
    Snell, Gregory
    Menahem, Solomon
    [J]. CHEST, 2017, 152 (04) : 1098A - 1098A
  • [36] PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPPRESSIVE THERAPY FOR DE NOVO KIDNEY TRANSPLANT RECIPIENTS IN RUSSIA
    Avxentyev, N. A.
    Derkach, E., V
    Prokopenko, E., I
    [J]. VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2019, 21 (01): : 23 - 34
  • [37] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Prokopenko, E. I.
    [J]. VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
  • [38] Results of a calcineurin-inhibitor-free immunosuppressive protocol in renal transplant recipients of expanded criteria deceased donors
    Re, L. S.
    Rial, M. C.
    Guardia, O. E.
    Galdo, M. T.
    Casadei, D. H.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (10) : 3468 - 3469
  • [39] THE TRANSFORM STUDY: INFECTION OUTCOMES WITH EVEROLIMUS PLUS REDUCED CALCINEURIN INHIBITOR AND MYCOPHENOLATE PLUS STANDARD CALCINEURIN INHIBITOR REGIMENS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pernin, V.
    Buchler, M.
    Cruzado, J.
    Garcia, V.
    Kuypers, D.
    Citterio, F.
    Huynh-Do, U.
    Luo, W. L.
    Bernhardt, P.
    Sommerer, C.
    Gharbi, H.
    Vincenti, F.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 23 - 23
  • [40] Factors affecting variability of sirolimus exposure in kidney transplant recipients on calcineurin inhibitor-free regimen
    Cattaneo, Dario
    Baldelli, Sara
    Cortinovis, Monica
    Perico, Norberto
    Gotti, Eliana
    Remuzzi, Giuseppe
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 475 - 475
12345